Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
12.93
-0.19 (-1.45%)
Dec 5, 2025, 4:00 PM EST - Market closed
Astria Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 738 | 505 | 279 | 389 | 70 | 43 | |
| Market Cap Growth | 42.79% | 80.99% | -28.37% | 454.95% | 63.15% | -38.35% | |
| Enterprise Value | 515 | 261 | 186 | 370 | 35 | -9 | |
| Last Close Price | 12.93 | 8.94 | 7.68 | 14.89 | 5.39 | 12.84 | |
| PS Ratio | 1045.48 | - | - | - | - | - | |
| PB Ratio | 5.29 | 1.58 | 1.15 | 1.76 | 0.57 | 1.06 | |
| P/TBV Ratio | 5.35 | 2.25 | 1.89 | 3.12 | 2.71 | 1.06 | |
| EV/Sales Ratio | 729.24 | - | - | - | - | - | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.03 | |
| Asset Turnover | 0.00 | - | - | - | - | - | |
| Quick Ratio | 10.42 | 17.15 | 21.35 | 24.99 | 24.12 | 7.03 | |
| Current Ratio | 10.78 | 17.49 | 21.73 | 25.13 | 24.42 | 7.25 | |
| Return on Equity (ROE) | -43.15% | -33.52% | -31.40% | -30.18% | -239.18% | -97.66% | |
| Return on Assets (ROA) | -26.93% | -23.36% | -17.47% | -18.67% | -21.69% | -52.44% | |
| Return on Capital (ROIC) | -29.17% | -24.55% | -18.21% | -19.39% | -23.08% | -58.72% | |
| Return on Capital Employed (ROCE) | -55.00% | -34.50% | -27.90% | -24.10% | -24.80% | -91.20% | |
| Earnings Yield | -16.80% | -18.68% | -26.15% | -13.32% | -277.97% | -86.78% | |
| FCF Yield | -16.30% | -16.16% | -24.56% | -11.21% | -43.03% | -75.66% | |
| Buyback Yield / Dilution | -14.24% | -86.44% | -106.03% | -63.81% | -191.81% | -63.87% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.